SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-15-229677
Filing Date
2015-06-22
Accepted
2015-06-22 08:53:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.6 TO SCHEDULE 14D-9 d931600dsc14d9a.htm SC 14D9/A 15146
  Complete submission text file 0001193125-15-229677.txt   16852
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filed by) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Subject) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-52299 | Film No.: 15943771
SIC: 2836 Biological Products, (No Diagnostic Substances)